FDA guidelines address journal reprints on unapproved drug use

02/24/2009 | American Medical News (subscription required)

The FDA has released guidelines concerning journal reprints distributed to physicians that cite the off-label use of drugs and devices. Although some welcome the guidelines as a way to help clear up the issues surrounding the practice, others say they may cause confusion about what should or should not be considered promotional.

View Full Article in:

American Medical News (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT